{"id":"https://openalex.org/W2010518325","doi":"https://doi.org/10.7326/0003-4819-144-5-200603070-00007","title":"Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost\u2013Utility Analysis","display_name":"Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost\u2013Utility Analysis","publication_year":2006,"publication_date":"2006-03-07","ids":{"openalex":"https://openalex.org/W2010518325","doi":"https://doi.org/10.7326/0003-4819-144-5-200603070-00007","mag":"2010518325","pmid":"https://pubmed.ncbi.nlm.nih.gov/16520473"},"language":"en","primary_location":{"id":"doi:10.7326/0003-4819-144-5-200603070-00007","doi":"https://doi.org/10.7326/0003-4819-144-5-200603070-00007","is_oa":false,"landing_page_url":"https://doi.org/10.7326/0003-4819-144-5-200603070-00007","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083277542","display_name":"Michael Patrick Pignone","orcid":"https://orcid.org/0000-0002-6657-7342","observed_orcids":["https://orcid.org/0000-0002-6657-7342"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Pignone","raw_affiliation_strings":["From University of North Carolina and RTI\u2013University of North Carolina Center for Health Promotion Economics, Chapel Hill, North Carolina; RTI Health Solutions, Research Triangle Park, North Carolina; and University of California, San Francisco, California","University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From University of North Carolina and RTI\u2013University of North Carolina Center for Health Promotion Economics, Chapel Hill, North Carolina; RTI Health Solutions, Research Triangle Park, North Carolina; and University of California, San Francisco, California","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I180670191","https://openalex.org/I4210120329"]},{"raw_affiliation_string":"University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089435449","display_name":"Stephanie Earnshaw","orcid":"https://orcid.org/0000-0003-2975-6509","observed_orcids":["https://orcid.org/0000-0003-2975-6509"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Earnshaw","raw_affiliation_strings":["From University of North Carolina and RTI\u2013University of North Carolina Center for Health Promotion Economics, Chapel Hill, North Carolina; RTI Health Solutions, Research Triangle Park, North Carolina; and University of California, San Francisco, California","University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From University of North Carolina and RTI\u2013University of North Carolina Center for Health Promotion Economics, Chapel Hill, North Carolina; RTI Health Solutions, Research Triangle Park, North Carolina; and University of California, San Francisco, California","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I180670191","https://openalex.org/I4210120329"]},{"raw_affiliation_string":"University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018381415","display_name":"Jeffrey A. Tice","orcid":"https://orcid.org/0000-0002-9857-2028","observed_orcids":["https://orcid.org/0000-0002-9857-2028"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Tice","raw_affiliation_strings":["From University of North Carolina and RTI\u2013University of North Carolina Center for Health Promotion Economics, Chapel Hill, North Carolina; RTI Health Solutions, Research Triangle Park, North Carolina; and University of California, San Francisco, California","University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From University of North Carolina and RTI\u2013University of North Carolina Center for Health Promotion Economics, Chapel Hill, North Carolina; RTI Health Solutions, Research Triangle Park, North Carolina; and University of California, San Francisco, California","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I180670191","https://openalex.org/I4210120329"]},{"raw_affiliation_string":"University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011978959","display_name":"Mark J. Pletcher","orcid":"https://orcid.org/0000-0002-6966-1312","observed_orcids":["https://orcid.org/0000-0002-6966-1312"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark J. Pletcher","raw_affiliation_strings":["From University of North Carolina and RTI\u2013University of North Carolina Center for Health Promotion Economics, Chapel Hill, North Carolina; RTI Health Solutions, Research Triangle Park, North Carolina; and University of California, San Francisco, California","University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From University of North Carolina and RTI\u2013University of North Carolina Center for Health Promotion Economics, Chapel Hill, North Carolina; RTI Health Solutions, Research Triangle Park, North Carolina; and University of California, San Francisco, California","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I180670191","https://openalex.org/I4210120329"]},{"raw_affiliation_string":"University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":16.5362,"has_fulltext":false,"cited_by_count":202,"citation_normalized_percentile":{"value":0.99444464,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"144","issue":"5","first_page":"326","last_page":"336"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.3617999851703644,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.3617999851703644,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.33329999446868896,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.2808000147342682,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9850000143051147},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8259999752044678},{"id":"https://openalex.org/keywords/primary-prevention","display_name":"primary prevention","score":0.8690000176429749},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cost-utility-analysis","display_name":"cost-utility analysis","score":0.7720000147819519},{"id":"https://openalex.org/keywords/middle-aged-men","display_name":"middle-aged men","score":0.7749999761581421},{"id":"https://openalex.org/keywords/10-year-cardiovascular-risk","display_name":"10-year cardiovascular risk","score":0.777999997138977},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8679999709129333},{"id":"https://openalex.org/keywords/hemorrhagic-stroke","display_name":"hemorrhagic stroke","score":0.890999972820282},{"id":"https://openalex.org/keywords/gastrointestinal-bleeding","display_name":"gastrointestinal bleeding","score":0.9779999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.946550726890564},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.9025871753692627},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.5969045162200928},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.46935755014419556},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.4660559594631195},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.46226561069488525},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4538324177265167},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.4448928236961365},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.43857690691947937},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.4107569754123688},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3803345263004303},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3396320939064026},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0713924765586853},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.06790247559547424},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006471","descriptor_name":"Gastrointestinal Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011322","descriptor_name":"Primary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.7326/0003-4819-144-5-200603070-00007","doi":"https://doi.org/10.7326/0003-4819-144-5-200603070-00007","is_oa":false,"landing_page_url":"https://doi.org/10.7326/0003-4819-144-5-200603070-00007","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},{"id":"pmid:16520473","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16520473","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of internal medicine","raw_type":"Journal Article"},{"id":"pmh:oai:bibmed.ucla.edu.ve:T070000062714/3","doi":null,"is_oa":false,"landing_page_url":"http://bibmed.ucla.edu.ve/cgi-win/be_alex.exe?Acceso=T070000062714/3&Nombrebd=bmucla","pdf_url":null,"source":{"id":"https://openalex.org/S7407064131","display_name":"UCLA - Biblioteca de Ciencias de la Salud","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I19325673","host_organization_name":"Universidad Centroccidental Lisandro Alvarado","host_organization_lineage":["https://openalex.org/I19325673"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G362531738","display_name":"Center for Excellence in Health Promotion Economics","funder_award_id":"1p30cd000138-01","funder_id":"https://openalex.org/F4320332162","funder_display_name":"Centers for Disease Control and Prevention"}],"funders":[{"id":"https://openalex.org/F4320332162","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W45288408","https://openalex.org/W94334450","https://openalex.org/W110902892","https://openalex.org/W1548123452","https://openalex.org/W1563323375","https://openalex.org/W1982412102","https://openalex.org/W1983625180","https://openalex.org/W1995904102","https://openalex.org/W2000702318","https://openalex.org/W2008049114","https://openalex.org/W2015137536","https://openalex.org/W2015421910","https://openalex.org/W2023798019","https://openalex.org/W2024352468","https://openalex.org/W2031968478","https://openalex.org/W2033156884","https://openalex.org/W2034456357","https://openalex.org/W2043180355","https://openalex.org/W2050977476","https://openalex.org/W2051922899","https://openalex.org/W2058025443","https://openalex.org/W2060939949","https://openalex.org/W2066589519","https://openalex.org/W2066891536","https://openalex.org/W2073069227","https://openalex.org/W2083855234","https://openalex.org/W2084576139","https://openalex.org/W2087395156","https://openalex.org/W2098961604","https://openalex.org/W2104305193","https://openalex.org/W2108298292","https://openalex.org/W2115131213","https://openalex.org/W2117459641","https://openalex.org/W2118598109","https://openalex.org/W2122558627","https://openalex.org/W2127670733","https://openalex.org/W2129750583","https://openalex.org/W2136486607","https://openalex.org/W2138597449","https://openalex.org/W2140348379","https://openalex.org/W2143321563","https://openalex.org/W2396548066","https://openalex.org/W2399650660","https://openalex.org/W2581407147","https://openalex.org/W2916530522","https://openalex.org/W4238251256","https://openalex.org/W4246979921","https://openalex.org/W4249825849"],"related_works":["https://openalex.org/W7101162574","https://openalex.org/W2091449905","https://openalex.org/W2439397368","https://openalex.org/W2301327972","https://openalex.org/W1972591668","https://openalex.org/W4233870975","https://openalex.org/W2270043737","https://openalex.org/W2152172298","https://openalex.org/W65827899","https://openalex.org/W7100089128"],"abstract_inverted_index":{"BACKGROUND:":[0],"Aspirin":[1],"and":[2,43,85,127,140,179,191,212,237],"statins":[3],"are":[4,124,215,222],"both":[5,41,98],"effective":[6,139,239],"for":[7,46,78,132,176,185,240,250],"primary":[8,48],"prevention":[9,49],"of":[10,30,33,50,69,75,134,148,159,189,194,258],"coronary":[11],"heart":[12],"disease":[13,71],"(CHD),":[14],"but":[15],"their":[16],"combined":[17],"use":[18],"has":[19],"not":[20,122,125],"been":[21],"well":[22],"studied.":[23],"OBJECTIVE:":[24],"To":[25],"perform":[26],"a":[27,67,96,129,149,259],"cost-utility":[28,157,202],"analysis":[29],"the":[31,47,187,192,201,268],"effects":[32,199],"aspirin":[34,136,152,168,233,262],"therapy,":[35,37,102],"statin":[36,150,260],"combination":[38,101],"therapy":[39,153,263],"with":[40,167,182,230],"drugs,":[42],"no":[44,104,144,231],"pharmacotherapy":[45],"CHD":[51,79,133,242,251,271],"events":[52,243],"in":[53,244],"men.":[54],"DESIGN:":[55],"Markov":[56],"model.":[57],"DATA":[58],"SOURCES:":[59],"Published":[60],"literature.":[61],"TARGET":[62],"POPULATION:":[63],"Middle-aged":[64],"men":[65,119,226,246],"without":[66],"history":[68],"cardiovascular":[70],"at":[72],"6":[73],"levels":[74],"10-year":[76,130,248,270],"risk":[77,131,175,184,249,272],"(2.5%,":[80],"5%,":[81],"7.5%,":[82,135],"10%,":[83],"15%,":[84],"25%).":[86],"TIME":[87],"HORIZON:":[88],"Lifetime.":[89],"PERSPECTIVE:":[90],"Third-party":[91],"payer.":[92],"INTERVENTIONS:":[93],"Low-dose":[94],"aspirin,":[95,183],"statin,":[97],"drugs":[99],"as":[100],"or":[103,254],"therapy.":[105],"OUTCOME":[106],"MEASURE:":[107],"Cost":[108],"per":[109,162],"quality-adjusted":[110,163],"life-year":[111,164],"gained.":[112],"RESULTS":[113,170],"OF":[114,171],"BASE-CASE":[115],"ANALYSIS:":[116,173],"For":[117],"45-year-old":[118],"who":[120],"do":[121],"smoke,":[123],"hypertensive,":[126],"have":[128],"was":[137],"more":[138,238,265],"less":[141,235],"costly":[142,236],"than":[143,277],"treatment.":[145],"The":[146,256],"addition":[147,257],"to":[151,224,261],"produced":[154],"an":[155],"incremental":[156],"ratio":[158],"56,200":[160],"dollars":[161],"gained":[165],"compared":[166],"alone.":[169],"SENSITIVITY":[172],"Excess":[174],"hemorrhagic":[177],"stroke":[178],"gastrointestinal":[180],"bleeding":[181],"CHD,":[186],"cost":[188],"statins,":[190],"disutility":[193],"taking":[195],"medication":[196],"had":[197],"important":[198],"on":[200],"ratios.":[203],"LIMITATIONS:":[204],"Several":[205],"input":[206],"parameters,":[207],"particularly":[208],"adverse":[209],"event":[210],"rates":[211],"utility":[213],"values,":[214],"supported":[216],"by":[217],"limited":[218],"empirical":[219],"data.":[220],"Results":[221],"applicable":[223],"middle-aged":[225,245],"only.":[227],"CONCLUSIONS:":[228],"Compared":[229],"treatment,":[232],"is":[234,252,275],"preventing":[241],"whose":[247],"7.5%":[253],"higher.":[255],"becomes":[264],"cost-effective":[266],"when":[267],"patient's":[269],"before":[273],"treatment":[274],"higher":[276],"10%.":[278]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}